Create a free QxMD account to receive personalized paper recommendations, relevant to your practice.

Get Started

JOURNAL ARTICLE

Severe acneiform skin reaction during therapy with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor

Tatjana Eames, Michael Landthaler, Sigrid Karrer

European Journal of Dermatology: EJD 2007, 17 (6): 552-3

No abstract text is available yet for this article.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Acneiform reaction to erlotinib. Peter C Schalock, Kathryn A Zug Dermatitis 2007, 18 (4): 230-1

Cutaneous adverse effects during therapy with an epidermal growth factor receptor (EGFR) inhibitor. Francesca Santoro, Emanuele Cozzani, Aurora Parodi Journal of Dermatological Treatment 2006, 17 (3): 160-1

Rosaceiform eruption induced by erlotinib. Annalisa Patrizi, Federica Bianchi, Iria Neri Dermatologic Therapy 2008, 21 Suppl 2: S43-5

[Contribution to acneiform eruptions by epidermal growth factor receptor inhibitors]. Domingo Bodet, Ramón Bartralot, Jordi Mollet, Cristina Heras, Vicente García-Patos Actas Dermo-sifiliográficas 2006, 97 (2): 148-9

Acneiform lesions secondary to ZD1839, an inhibitor of the epidermal growth factor receptor. M Fernandez-Galar, A España, J M López-Picazo Clinical and Experimental Dermatology 2004, 29 (2): 138-40

Treatment of epidermal growth factor receptor inhibitor-induced acneiform eruption with topical recombinant human epidermal growth factor. J U Shin, J H Park, B-C Cho, J H Lee Dermatology: International Journal for Clinical and Investigative Dermatology 2012, 225 (2): 135-40

Epidermal growth factor receptor inhibitor-related folliculitis. Navdeep Tangri, Anwar Al Hammadi, William Gerstein Dermatitis 2007, 18 (3): 178-9

Erlotinib-related skin toxicities: treatment strategies in patients with metastatic non-small cell lung cancer. Yoshio Kiyohara, Naoya Yamazaki, Akiko Kishi Journal of the American Academy of Dermatology 2013, 69 (3): 463-72

Erlotinib-induced pustular eruption. F Cusano, G Ferrara, E Barletta, V Ingordo Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale, Società Italiana di Dermatologia e Sifilografia 2009, 144 (1): 93-6

Markers in the epidermal growth factor receptor pathway and skin toxicity during erlotinib treatment. A R Tan, S M Steinberg, A L Parr, D Nguyen, S X Yang Annals of Oncology: Official Journal of the European Society for Medical Oncology 2008, 19 (1): 185-90

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Severe acneiform skin reaction during therapy with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips